Stifel Financial Corp Novavax Inc Transaction History

Stifel Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $107,425 - $222,933	-2,961 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $27,543 - $56,445	395 Added 15.39%	2,961 $218,000
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $176,139 - $285,322	-1,309 Reduced 33.78%	2,566 $367,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $71,475 - $108,773	402 Added 11.58%	3,875 $804,000
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $78,045 - $166,197	645 Added 22.81%	3,473 $738,000
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $150,376 - $425,826	-1,331 Reduced 32.0%	2,828 $512,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $52,519 - $93,046	667 Added 19.1%	4,159 $464,000
Q3 2020 Nov 16, 2020	BUY	$79.44 - $178.51 $277,404 - $623,356	3,492 New	3,492 $378,000

287

94.6M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $660M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.